LINC01687

Across TCGA pan-cancer cohorts, LINC01687 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01687 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC01687 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01687 expression acts as an unfavorable survival marker, although some lineages such as BRCA and SKCM show a favorable association.

CHOL, KIRP, and UVM are the cancer types where LINC01687 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	II,III,IV	0.066	0.761	<.001	90	view →
KIRP	DFS	Tertile	All	0.807	0.937	<.001	40	view →
UVM	OS	Tertile	All	0.321	0.698	.008	18	view →
LUAD	DFS	Quartile	IV	0.132	0.687	.003	18	view →
BRCA	DFS	Median	IV	0.879	0.542	.010	16	view →
SARC	OS	Quartile	All	0.748	0.864	.010	15	view →
THCA	OS	Tertile	III,IV	0.240	0.795	.013	12	view →
KIRC	DFS	Tertile	All	0.459	0.686	.005	12	view →
SKCM	DFS	Median	All	0.252	0.162	.008	11	view →
BLCA	DFS	Quartile	IV	0.244	0.517	.019	9	view →
PCPG	OS	Tertile	All	0.944	1.000	.045	9	view →
COAD	OS	Median	III,IV	0.417	0.605	.038	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC01687–CHOL (OS)

Open the CHOL breakdown →